CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding CalciMedica, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 12 | 20 | +8 |
| Shares | 518.2K | 3.55M | +3.03M (+585.0%) |
| Value | $1.49M | $14.8M | +$13.3M (+894.1%) |
New holders (9)
Institutions that held CalciMedica, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,000,000 | $4.16M | 0.07% |
| Soleus Capital Management, L.P. | 783,904 | $3.26M | 0.29% |
| Stonepine Capital Management, LLC | 522,602 | $2.17M | 1.72% |
| Aisling Capital Management LP | 521,114 | $2.17M | 0.73% |
| Alyeska Investment Group, L.P. | 75,082 | $312.3K | 0.00% |
| Millennium Management LLC | 66,134 | $275.1K | 0.00% |
| Vanguard Group Inc | 13,359 | $55.6K | 0.00% |
| ADAR1 Capital Management, LLC | 781 | $3.25K | 0.00% |
| JPMorgan Chase & Co | 14 | $58 | 0.00% |
Sold out (1)
Institutions that held CalciMedica, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Cutler Group LP | 14 | $0 |